Loading...
Price History
Market Data
| Market Cap | - |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | 1.83 |
| Dividend Yield | - |
| D/E Ratio | 0.32 |
| Current Ratio | 3.72 |
| Currency | USD |
Key Financial Metrics
6.07B
Revenue
1.07B
Net Income
1.83
EPS (Diluted)
2.02B
Free Cash Flow
Profitability
Gross Margin
78.0%
Operating Margin
20.8%
Net Profit Margin
17.7%
EBITDA
1.53B
Returns & Efficiency
Return on Assets (ROA)
7.8%
Return on Equity (ROE)
10.4%
Dividend Yield
-
EPS
1.83
Financial Health
Total Assets
13.70B
Total Debt
598.30M
Debt to Equity
0.32x
Current Ratio
3.72
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| HQ | IRVINE, CA |
| Fiscal Year | 2025 |
Peers
187.84B
P/E: --
STERIS PLC
STE
25.56B
P/E: --
17.16B
P/E: --
17.16B
P/E: --
ALIGN TECHNOLOGY INC
ALGN
12.23B
P/E: --
ENOVIS CORP
ENOV
1.32B
P/E: --
--
P/E: --
--
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap-
P/E Ratio (TTM)-
Price to Book-
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin78.0%
Operating Margin20.8%
Net Margin17.7%
ROE10.4%
ROA7.8%
Leverage & Liquidity
Debt to Equity0.32
Current Ratio3.72
Total Debt$598.30M
Total Assets$13.70B
Stockholders' Equity$10.34B
Income Statement (FY 2025)
Revenue$6.07B
Gross Profit$4.73B
Operating Income$1.26B
Net Income$1.07B
EPS (Diluted)$1.83
Cash Flow (FY 2025)
Free Cash Flow$2.02B
Cash & Equivalents$2.94B
Revenue Growth11.5%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | ONE EDWARDS WAY IRVINE, CA 92614 |
| Phone | 9492502500 |
| Incorporated | DE, US |
| EIN | 364316614 |
| Fiscal Year End | 1231 |
| Stockholders' Equity | $10.34B |
| Cash & Equivalents | $2.94B |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-11
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-11
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-02
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-26
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-26
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-25
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-23
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-23
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-17
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-13
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-12
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-10
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | EDWARDS LIFESCIENCES CORP |
| Ticker | EW |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | -- |
| Headquarters | IRVINE, CA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | - |
| Revenue | 6.07B |
| Net Income | 1.07B |
| P/E Ratio | - |
| EPS | 1.83 |
| Net Margin | 17.7% |
| ROE | 10.4% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...